Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Emapalumab × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphohistiocytosis, Hemophagocytic 1

Interventions

nilotinib 6 bosutinib 4 asciminib 3 Imatinib Mesylate 3 Decitabine 3 decitabine and cedazuridine drug combination 2 cedazuridine 2 avapritinib 2 Dasatinib 2 treosulfan 1 tagraxofusp 1 pemigatinib 1 luspatercept 1 ivosidenib 1 imetelstat 1 glasdegib 1 enasidenib 1 GRN163L peptide 1 Emapalumab 1 Daunorubicin 1 Cytarabine 1 Busulfan 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01818492 2023-02-21

Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis

Swedish Orphan Biovitrum

Phase 2/3 Completed

45 enrolled 20 charts 1 FDA

Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡